Supportive Care as Primary Treatment for Uncomplicated Chickenpox

Primary Treatment Recommendation

Evidence on Oral Acyclovir in Healthy Children

Supportive Care Measures (All Patients)

High‑Risk Groups Requiring Consideration of Acyclovir

Immunocompromised Patients

Monitoring for Complications

Isolation and Infection‑Control Measures

Post‑Exposure Prophylaxis for Household Contacts

Duration of Treatment and Follow‑Up

Vaccination Considerations After Natural Infection

Common Pitfalls to Avoid

Cetirizine Use for Itch Management in Pediatric Varicella

Efficacy of Cetirizine

• The American Academy of Dermatology notes that cetirizine may be used to relieve itching in uncomplicated varicella in healthy children ≥ 2 years, but it should not replace proper topical care and the evidence for varicella‑specific pruritus relief is limited. 7
• Oral antihistamines, including cetirizine, have insufficient evidence to recommend routine use for pruritus in dermatologic conditions such as atopic dermatitis, and this limitation extends to varicella‑related itching. 7
• Non‑sedating antihistamines (e.g., cetirizine) are ineffectual for itch relief in most skin disorders because histamine is not the primary mediator of varicella‑associated pruritus. 7
• In the large ETAC trial of children aged 12–24 months, cetirizine did not significantly improve overall skin disease control compared with placebo. 7
• Only four‑fold higher doses (≈ 40 mg daily) of cetirizine produced any measurable benefit in adults with skin conditions, and the effect is likely due to sedation rather than true antihistamine action. 7
• Sedating antihistamines (not cetirizine) may provide short‑term improvement in sleep loss secondary to nighttime itching, but this benefit derives from sedation, not antipruritic activity, and they should never replace proper topical management. 7

Dosing Recommendations (If Cetirizine Is Chosen)

• Standard pediatric dosing (American Academy of Dermatology):
  
  • Children 2–5 years (≥ 15 kg): 2.5 mg once daily; may be increased to 5 mg once daily or 2.5 mg twice daily. 8
  • Children ≥ 6 years: 5–10 mg once daily. 8
• At standard doses cetirizine is classified as a non‑sedating antihistamine, although occasional sedation can occur. 7

Safety Considerations

• Aspirin and other salicylates must be avoided in children with varicella because of the established risk of Reye syndrome. [8][9]

Practical Itch‑Management Algorithm (Based on Evidence)

• First‑line: supportive skin care (lukewarm oatmeal baths, nail trimming, adequate hydration).
• If sleep is disrupted and supportive measures are insufficient, a sedating antihistamine (e.g., diphenhydramine oral at bedtime) may be considered for its sedative effect—not for antipruritic action. 7
• Cetirizine may be added only with the expectation of minimal benefit beyond placebo; it should not be used as the primary itch‑control strategy. 7
• Never substitute antihistamines for proper topical and supportive care. 7